IGDCC4 and hepatocellular carcinoma: Regarding Igdcc4, also described as being involved in immune response (Sanz-Pamplona et al., 2014) and a biomarker in hepatocellular carcinoma (Zweerink et al., 2020), further studies should investigate its precise role in microglia.